ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

AURA Aura Biosciences Inc

7,36
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 13:00:12
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aura Biosciences Inc AURA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 7,36 13:00:12
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,36
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.5.202422:05GLOBEAura Biosciences to Participate in the Jefferies Global..
23.5.202414:00GLOBEAura Biosciences to Host Virtual KOL Event “Pioneering a New..
09.5.202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202413:05EDGAR2Form 8-K - Current report
09.5.202413:00GLOBEAura Biosciences Reports First Quarter 2024 Financial..
08.5.202413:00GLOBEAura Biosciences to Participate in Upcoming Investor..
27.3.202412:00BWAura Biosciences Reports Fourth Quarter and Full Year 2023..
04.3.202423:35EDGAR2Form 144 - Report of proposed sale of securities
26.2.202413:00BWAura Biosciences to Participate in Upcoming Investor..
23.2.202422:22EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:01EDGAR2Form 144 - Report of proposed sale of securities
08.1.202422:11EDGAR2Form 144 - Report of proposed sale of securities
08.1.202413:31EDGAR2Form 8-K - Current report
02.1.202422:29EDGAR2Form 144 - Report of proposed sale of securities
15.12.202322:30EDGAR2Form 144 - Report of proposed sale of securities
07.12.202314:00BWAura Biosciences Announces First Patient Dosed in Global..
09.11.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202322:15EDGAR2Form 8-K - Current report
09.11.202322:05BWAura Biosciences Reports Third Quarter 2023 Financial..
08.11.202313:00BWAura Biosciences to Participate in Upcoming Investor..
08.11.202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202300:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07.11.202304:02BWAura Biosciences Announces Pricing of Public Offering of..
06.11.202322:22EDGAR2Form 144 - Report of proposed sale of securities
06.11.202322:20EDGAR2Form 144 - Report of proposed sale of securities
06.11.202322:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06.11.202322:08BWAura Biosciences Announces Proposed Public Offering of..
06.11.202322:01EDGAR2Form 8-K - Current report
06.11.202321:50DJNAura Biosciences Gets FDA Agreement Regarding Phase 3..
06.11.202321:00BWAura Biosciences Receives FDA Agreement Under Special..
03.11.202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:16EDGAR2Form 144 - Report of proposed sale of securities
03.11.202321:15EDGAR2Form 144 - Report of proposed sale of securities
03.11.202321:15EDGAR2Form 144 - Report of proposed sale of securities
01.11.202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202321:05BWAura Biosciences to Present Updated Phase 2 Data Evaluating..
24.10.202302:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.10.202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202322:11EDGAR2Form 8-K - Current report
02.10.202322:05BWAura Biosciences Strengthens and Expands Leadership Team..
09.8.202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202313:05EDGAR2Form 8-K - Current report
09.8.202313:00BWAura Biosciences Reports Second Quarter 2023 Financial..